[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:amyotrophic-lateral-sclerosis:superoxide-dismutase-cu-zn":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Amyotrophic Lateral Sclerosis","Superoxide Dismutase [Cu-Zn]",4,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05407324","Dazucorilant in Patients With Amyotrophic Lateral Sclerosis",[12],"Phase 2","RECRUITING","2026-08-26T02:16:44.178623Z","2026-07-05T05:32:16.799228Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07290062","A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)",[20],"Phase 1","2026-08-26T02:18:36.226508Z","2026-05-05T02:43:27.494050Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07259980","A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)",[],"2026-08-26T02:18:43.501109Z","2026-05-13T02:55:06.681439Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT03865420","Amyotrophic Lateral Sclerosis (ALS) Families Project",[],"2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.179000Z"]